Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Cognitive Performance
100%
Parkinson's Disease
100%
Parkinson Patients
100%
Neuropsychiatric Symptoms
100%
Cognitive Impairment
83%
Healthy Controls
66%
Depressive Symptoms
33%
Psychosis
33%
Impulse Control Disorders
33%
Apathy
33%
Between-groups Differences
33%
Patient-controlled
16%
Quality of Life
16%
Clinically Significant
16%
Baseline Data
16%
Untreated Patients
16%
Demographic Characteristics
16%
Neuropsychological Battery
16%
Neuropsychological Tests
16%
Disease States
16%
Disease Course
16%
Mild Cognitive Impairment
16%
Cognitive Assessment
16%
Normal Cognition
16%
Patients with Parkinson's Disease
16%
Cognitive Ability
16%
Recommended Screening
16%
Traditional Criterion
16%
Untreated Disease
16%
Testing Criteria
16%
Parkinson's Progression Markers Initiative
16%
Dopamine Replacement Therapy
16%
Anxiety-depressive Disorders
16%
Biological Predictors
16%
Site Study
16%
Psychology
Cognitive Performance
100%
Cognitive Impairment
100%
Impulse Control
40%
Group Difference
40%
Cognitive Function
20%
Quality of Life
20%
Demographic Characteristic
20%
Cognitive Assessment
20%
Mild Cognitive Impairment
20%
Dopamine
20%
Neuroscience
Parkinson's Disease
100%
Neuropsychiatric Symptom
100%
Cognitive Disorders
45%
Impulse Control Disorder
18%
Psychosis
18%
Dopaminergic
9%
Mild Cognitive Impairment
9%
Cognitive Function
9%
Dopamine
9%
Quality of Life
9%